EDX Medical publishes Annual Report and Notice of AGM

EDX Medical Group Plc (AQSE: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, heart disease and infectious diseases, has announced that its annual general meeting (AGM) will be held at Mezzanine Room, 1 Wimpole Street, Westminster, London, W1G 0AE on 30 September 2024 at 2:00 p.m.

The annual report and financial statements for the year ended 31 March 2024, Notice of AGM and Form of Proxy will be posted today, 4 September 2024, to eligible shareholders.

31Mar24-EDX-Medical-Group-plc-ARA-final Download

Share on:

You might also enjoy reading EDX Medical Group to complete the development of new pneumonia test

Written by: Amilia Stone

Find more news, interviews, share price & company profile here for:
EDX Medical Group Plc

Latest Company News

EDX Medical secures up to £4m to accelerate diagnostic product development

October 20, 2025

EDX Medical has raised up to £4 million to advance its digital diagnostic products for cancer, cardiovascular, and infectious diseases. The funding includes a £2 million share placing at 14p per share and a £2 million convertible loan note from founder Professor Sir Chris Evans.

EDX Medical launches TC100, UK’s most advanced testicular cancer testing service

October 7, 2025

EDX Medical Group plc has commenced marketing its TC100 testicular cancer testing service, described as the most advanced of its kind in the UK.

EDX Medical confirms date for 2025 Annual General Meeting

September 1, 2025

EDX Medical will hold its AGM on 29 September 2025 at 2:00 p.m. at the Marcus Beck Library, Royal School of Medicine, London. The meeting will cover standard business matters and provide shareholders with an update on company progress.